• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 85 of 100
AbbVie Inc. To Buy Shire For $54.8 Billion
HealthShire-Baxalta $32 Billion Merger Talks Said to Advance
By Michal AddadyJanuary 3, 2016
US-CRIME-JUSTICE-SHKRELI
HealthMartin Shkreli’s Old Company Has Filed For Bankruptcy
By ReutersDecember 30, 2015
sb10065848dh-001
TechNew Research Shows How the Liver Fights off Sugar Cravings
By Hilary BrueckDecember 29, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
LeadershipValeant Will Be Run by a Group of Executives Until Its CEO Returns
By ReutersDecember 28, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
LeadershipValeant CEO J. Michael Pearson Hospitalized for ‘Severe’ Pneumonia
By ReutersDecember 26, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthAftershocks Keep Coming After Former Pharma CEO’s Arrest
By ReutersDecember 23, 2015
Inside Teva Pharmaceuticals Headquarters
HealthCelgene Settles U.S. Patent Litigation for Revlimid
By Reuters and Aaron TaskDecember 22, 2015
APTOPIX Shkreli Arrest
FinanceKaloBios Just Fired Martin Shkreli as CEO
By Laura LorenzettiDecember 21, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthMartin Shkreli Says This Is the Real Reason He Was Arrested
By Michal AddadyDecember 21, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthMartin Shkreli’s Twitter Account Hacked
By Reuters and Aaron TaskDecember 20, 2015
Martin Shkreli arrested
HealthMartin Shkreli’s Arrest Halts Leukemia Drug Trial
By Michal AddadyDecember 20, 2015
Martin Shkreli Says Securities Fraud Charges Are ‘Baseless’
LeadershipMartin Shkreli Says Securities Fraud Charges Are ‘Baseless’
By ReutersDecember 19, 2015
Inside of a Gilead Sciences Lab
FinanceIsis Pharmaceuticals Changes Its Name After Terrorists Attack Stock Price
By Jen WiecznerDecember 18, 2015
US-CRIME-JUSTICE-SHKRELI
HealthTuring Replaces Martin Shkreli with Interim CEO
By Laura LorenzettiDecember 18, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
LeadershipMartin Shkreli’s 15 Minutes Are Up
By Geoff ColvinDecember 18, 2015
1...
  • 83
  • 84
  • 85
  • 86
  • 87
...100
Most Popular
Economy
The affordability crisis is so bad that, for the first time ever, both mom and dad are working full-time in most American familiesplaceholder alt text
By Jacqueline MunisJune 17, 2026
Personal Finance
Current price of oil as of June 17, 2026placeholder alt text
By Joseph HostetlerJune 17, 2026
Arts & Entertainment
Exclusive: Universal beat Disney as Hollywood's maker of the most expensive movie of all time placeholder alt text
By Christian SyltJune 17, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.